Yanjun Tian

Mrs. Yanjun Tian

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
HLHaiqing Liu
Haiqing Liu
YTYanjun Tian
Yanjun Tian
BJBingyuan Ji
Bingyuan Ji
LHLu Hai
Lu Hai
QXQing Xin
Qing Xin
BBBo Bai
Bo Bai

10 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
YTYanjun Tian
Yanjun Tian
HLHaiqing Liu
Haiqing Liu
MWMengwei Wang
Mengwei Wang
RWRuihao Wang
Ruihao Wang
GYGuandong Yi
Guandong Yi
RCRuijiao Chen
Ruijiao Chen
Signal transducer and activator of transcription 3 (STAT3) and nuclear factor erythroid-derived 2-like 2 (NRF2, also known as NFE2L2), are two of the most complicated transcription regulators, which participate in a variety of physiological processes. Numerous studies have shown that they are overactivated in multiple types of tumors. Interestingly, STAT3 and NRF2 can also interact with each other to regulate tumor progression. Hence, these two important transcription factors are considered key targets for developing a new class of antitumor drugs. This review summarizes the pivotal roles of the two transcription regulators and their interactions in the tumor microenvironment to identify potential antitumor drug targets and, ultimately, improve patients’ health and survival.

22 May 2025 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
XHXiaohang Hu
Xiaohang Hu
JGJing Guo
Jing Guo
HSHaiyang Sang
Haiyang Sang
JYJinyan Yan
Jinyan Yan
HCHong Chang
Hong Chang
LJLiqing Jiang
Liqing Jiang
Introduction: Individuals with balanced chromosomal rearrangements are at an increased risk for infertility, recurrent miscarriages, and the birth of infants with congenital malformations. Traditional cytogenetic techniques are limited by their low resolution, whereas optical genome mapping offers enhanced capabilities for detecting chromosomal rearrangements and determining genomic localization and orientation. This study sought to evaluate the efficacy of optical genome mapping in identifying complex balanced chromosomal rearrangements that may contribute to fertility challenges.Case presentation: A 21-year-old Asian female patient with a history of recurrent abortions was included in the study. Peripheral blood samples were collected for high-resolution karyotyping, chromosomal microarray analysis, and optical genome mapping. The high-resolution karyotype analysis identified complex chromosomal abnormalities. Optical genome mapping has revealed additional cryptic chromosomal aberrations, such as ins (2; 12) (p16.1; q12q12), inv (6) (q21q21), and inv (12) (q12q12), offering a novel perspective on this case. Notably, the disrupted genes, including CRIM1, MUC19, and PRDM1, have not been classified as pathogenic by existing databases.Conclusion: This study underscores the capability of optical genome mapping to deliver comprehensive and precise information. It is anticipated that optical genome mapping will emerge as a valuable cytogenetic tool within clinical genetic methodologies, providing new references and insights for clinical practice in the future.

7 July 2025 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
LJLiqing Jiang
Liqing Jiang
JLJiaqi Li
Jiaqi Li
AHAizhong Han
Aizhong Han
FHFei Hou
Fei Hou
XWXiaotong Wei
Xiaotong Wei
YTYanjun Tian
Yanjun Tian
Background: At present, there are few reports on 9q21.13 microdeletion syndrome, which is characterized by intellectual disability, epilepsy, autistic behaviour, and recognizable facial features, etc. The aim of this study is to enrich the phenotypic features of 9q21.13 microdeletion syndrome and expand the possible segments of 9q21.13 microdeletion syndrome.Methods: Four individuals from a 3-generation Chinese family with epilepsy, intellectual disability, and speech disorders were recruited in this study. Whole exome sequencing (WES) and chromosome microarray analysis (CMA) techniques were used for genetic testing. The pathogenicity of CNVs was interpreted following the American College of Medical Genetics (ACMG) standards and guidelines.Results: A 9q21.13 microdeletion with a fragment size of approximately 2.35 Mb was identified in the proband, the proband’s mother and grandmother and even the fetus. And this region encompasses 6 protein coding genes, namely, ALDH1A1, ANXA1, GDA, RORB, TMC1, and ZFAND5.Conclusion: In this article, we report a girl with epilepsy, intellectual disability, speech disorders, delayed motor development, and autism. We identified a novel 9q21.13 microdeletion with a fragment size of approximately 2.35 Mb in 4 individuals from a 3-generation Chinese family by WES and CMA techniques. Within the region, the RORB gene is a strong candidate gene for complex neurodevelopmental disorders. Herein, we speculate that RORB makes a significant contribution to the clinical phenotypes caused by 9q21.13 microdeletion.